EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities

Elisa Bianconi iD, Emidio Camaioni iD, Paulina Oszajca iD, Antonio Macchiarulo iD

ChemMedChem · 12.11.2026 · 21 (21)

DOI: 10.1002/cmdc.70478 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 31.10.2026. Verfasst von Elisa Bianconi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Snake Bites, Antidotes, Drug Discovery, Antivenins. Die Arbeit nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snakebite envenoming is acknowledged as neglected tropical disease affecting populations of regions with limited access to healthcare systems. However, it had posed a major threat to human health since classical antiquity, when plant‐ and animal‐based remedies were extensively used as antidotes to counteract bites by venomous snakes. Although the provision of safe and effective treatments by 2030 is among the strategic objectives of the World Health Organization, clinically approved therapies currently available remain animal‐derived polyclonal antibodies, which suffer from significant limitations, including high production costs, limited cross‐species efficacy, and risk of adverse immune reactions. In this review, we survey some historical antidotes used to treat snakebite envenoming in classical antiquity and early modern Europe such as theriac, mithridatum, Orvietan and Mattioli's scorpion oil. We then discuss natural compounds that, while found also as active ingredients in medical plants used for the preparation of the historical antidotes, over the last decades have inspired research efforts aimed at characterizing their evidence‐based antivenom activity with the aim of offering potential alternatives to biologic‐based therapies. Finally, we outline emerging therapeutic opportunities that, arising from drug repurposing efforts, may pave the way for the development of novel, broadly effective therapies against multiple venomous snake species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Snake BitesAntidotesDrug DiscoveryAntiveninsBiological ProductsHumansAnimalsVenomous Snakes

Stichwörter der Autor:innen

drug repurposinghistorical antidotesrosmarinic acidsnakebitevarespladib

Substanzen

AntidotesAntiveninsBiological Products

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
  • Swiss Society for the History of Pharmacy, Zurich, Switzerland.

ORCID-Profile: Elisa Bianconi, Emidio Camaioni, Paulina Oszajca, Antonio Macchiarulo

Zitieren

APA

Bianconi, E., Camaioni, E., Oszajca, P., & Macchiarulo, A. (2026). Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70478

Vancouver

Bianconi E, Camaioni E, Oszajca P, Macchiarulo A. Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70478

BibTeX
@article{Bianconi2026,
  author = {Bianconi, Elisa and Camaioni, Emidio and Oszajca, Paulina and Macchiarulo, Antonio},
  title = {Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70478}
}
Kostenlos starten →